Characterization and Suppression of a Potential Side Reaction During Monobenzyl-protected Phosphoserine Coupling
スポンサーリンク
概要
- 論文の詳細を見る
- 2013-03-01
著者
-
LIU Baosheng
American Peptide Company
-
NEMOTO Yoshitaka
American Peptide Company
-
LIU Liang
American Peptide Company, Inc. Head Quarter
-
HALLER Patricia
American Peptide Company, Inc. GMP Facility
-
NGUYEN Thuy
American Peptide Company, Inc. GMP Facility
-
SELF Michael
American Peptide Company, Inc. GMP Facility
-
ALMAGUER Nicholas
American Peptide Company, Inc. GMP Facility
-
WU Fengyi
American Peptide Company, Inc. GMP Facility
-
SHAKOORI Firuz
American Peptide Company, Inc. GMP Facility
-
JIANG J.
American Peptide Company, Inc. GMP Facility
関連論文
- Human Antithrombin III-Derived Heparin-Binding Peptides (HBPs); Characterization and Further Investigation of Potent Analogues
- The Relaxation Effects of VIP and its C-terminal Deleted Peptides on Mouse Stomach
- Characterization of Heparin Binding Sites in Antithrombin III, and Novel Heparin Binding Peptide-Coupled Affinity Chromatography for Low Molecular Weigh Heparin
- Chemical Synthesis and Application of C-Terminally 5-Carboxyfluorescein-labelled Thymopentin as a Fluorescent Probe for Thymopoietin Receptor
- The Interaction Studies of VIP and VIP Analogues with Glycosaminoglycan
- Enzymatic Peptide Synthesis : Transesterification Catalyzed by Chymotrypsin
- Structure-Activity Relationship Studies of PACAP-27 and VIP Analogues
- Studies of Amino Acids Analysis Using Aminopeptidase M-Catalyzed Hydrolysis
- Characterization and Suppression of a Potential Side Reaction During Monobenzyl-protected Phosphoserine Coupling